Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

List includes medications for diabetes, cancer, arthritis, and more ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...

The Trump administration says that while it is pushing for lower prices in the U.S. drugmakers will be able to make up the ...

As Maryland moves toward price limits on certain prescription drugs, patients continue searching for affordable options at the pharmacy.